Aman Agarwal

Aman Agarwal is a former computational biologist and Chartered Accountant whose current professional role and primary location remain undisclosed. He previously operated as a life sciences researcher specializing in immunology, where he directly contributed to the successful development of the first oral COVID-19 vaccine. During his scientific career, his computational biology research and data analysis were featured in top-tier, peer-reviewed academic journals, specifically including Nature and Cell. Agarwal possesses a highly specialized dual background, combining deep domain expertise in biotechnology and pharmaceutical development with formal financial qualifications achieved through his Chartered Accountant certification. This combination of rigorous scientific research experience and financial literacy positions him uniquely within the broader life sciences and venture capital sectors. His professional focus bridges the intersection of advanced computational biology and financial analysis, leveraging his global health milestones to evaluate complex biotech initiatives.